Skip to main content
. 2026 Jan 20;18(1):8. doi: 10.21037/jtd-2025-1861

Figure 3.

Figure 3

Subgroup analysis of NSCLC patients between the AM and PM groups. CI, confidence interval; HR, hazard ratio; NSCLC, non-small cell lung cancer.